In a recent study Zhou et al. demonstrated that cancer exosome-derived miR-105 can effectively weaken the tight junctions between endothelial cells by reducing ZO-1 expression in endothelial cells hence making the endothelial barrier more permeable for cancer cells [94]. The gene discussed is TJP1; the disease is cancer.